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Available online 5 March 2016AbstractIn human, the cytoplasmic (cLysRS) and mitochondrial (mLysRS) species of lysyl-tRNA synthetase are encoded by a single gene. Following
HIV-1 infection, mLysRS is selectively taken up into viral particles along with the three tRNALys isoacceptors. The GagPol polyprotein precursor
is involved in this process. With the aim to reconstitute in vitro the HIV-1 tRNA3
Lys packaging complex, we first searched for the putative
involvement of another viral protein in the selective viral hijacking of mLysRS only. After screening all the viral proteins, we observed that Vpr
and Rev have the potential to interact with mLysRS, but that this association does not take place at the level of the assembly of mLysRS into the
packaging complex. We also show that tRNA3
Lys can form a ternary complex with the two purified proteins mLysRS and the Pol domain of
GagPol, which mimicks its packaging complex.
© 2016 The Authors. Published by Elsevier B.V. on behalf of Socie´te´ Franc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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An essential process in the viral life cycle of HIV-1, the
human immunodeficiency virus type 1, is the conversion of its
viral genomic RNA (vRNA) into proviral DNA. One of the
crucial step of this mechanism is viral packaging of tRNA3
Lys
from the host cell, a molecule that serves as a primer for
initiation of reverse transcription [1]. Even though formation
of a specific vRNA/tRNA3
Lys complex primarily involves
annealing of the 30-terminal 18 nucleotides of tRNA3
Lys to the
complementary sequence located in the 50-untranslated region
of vRNA corresponding to the primer binding site (PBS), the
complete process of initiation and transition to elongation
requires a more complex pattern of interactions [2]. Because
initiation of reverse transcription starts after maturation of new
viral particles before infection of target cells, or before* Corresponding author. Tel.: þ33 1 69 82 35 05; fax: þ33 1 69 82 31 29.
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ndisruption of the capsid following infection, packaging of
tRNA3
Lys during viral assembly is essential to produce effective
virions [3]. However, the three tRNALys isoacceptors are
present in the virus [4], including tRNA1
Lys and tRNA2
Lys that
cannot anneal to the PBS, which establishes that vRNA/tRNA
annealing is not responsible for tRNA packaging.
Lysyl-tRNA synthetase (LysRS) from infected cells, the
enzyme that aminoacylates tRNA3
Lys to give the aminoacyl-
tRNA used for protein synthesis, is also packaged into HIV-
1 particles [5,6]. Human LysRS possesses a 73 amino acid
residue N-terminal polypeptide extension that contributes a
potent tRNA-binding domain [7,8] required for efficient tRNA
packaging [9]. Although it has long been believed that cyto-
solic LysRS (cLysRS) was involved in this process [5], the
actual source of LysRS present in the virions is the mito-
chondrial enzyme [6]. Maturation of pmLysRS, the precursor
of mitochondrial LysRS (mLysRS), after cleavage of its
mitochondria-targeting sequence between Gly30 and Gln31
upon translocation into mitochondria, generates an active
enzyme with potent tRNA-binding properties [10].nc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open access
c-nd/4.0/).
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precursor containing the matrix (MA), capsid (CA), nucleo-
capsid (NC) and p6 proteins (Fig. 1A). The GagPol poly-
protein precursor containing the transframe (TF, also named
p6*), protease (PR), reverse transcriptase (RT) and integrase
(IN) proteins in addition to MA, CA and NC, is produced via a
1 ribosomal frameshifting occurring between the NC and p6
coding regions of gag (Fig. 1A). It is believed that the TF and
IN domains or the Pol region of the GagPol polyprotein pre-
cursor form molecular tweezers that interact with the catalytic
domain of mLysRS to build the GagPol:mLysRS:tRNA3
Lys
packaging complex [11]. The Gag and GagPol polyprotein
precursors are maturated into the virions via the viral protease
to generate individual proteins, thus releasing tRNA3
Lys into the
virus particle, which allows initiation of reverse transcription
to occur.Fig. 1. Two-hybrid analysis of LysRS:pHIV-1 interaction. (A) The complete genom
Vpr, Tat, Rev, Vpu and Nef are encoded on the three reading frames of the viral geno
The two-hybrid protein:protein interaction assay between pHIV-1, and cLysRS, mL
for the cytoplasmic (cLysRS), mitochondrial (mLysRS), and premitochondrial (pmL
the control of a galactose-inducible promoter in pJG4-5. As a control, all the strains
the strains were plated on a galactose medium in the absence of leucine (YNBGal)
observed following coexpression of any of the three LysRS species with Nef, Vpr,
pHIV-1, then strains should not grow in the absence of leucine on a glucose mediu
presence of leucine (not shown). (C) Expression and stability of the fusion proteins
in yeast from the pJG4-5 plasmid. The cLysRS, mLysRS or pmLysRS species (80 k
blot analysis of the fusion proteins expressed in yeast from the pEG202 plasmid
(34.4 kDa), Nef (46 kDa) and Env (119.7 kDa) fusion proteins were expressed fuWhereas cLysRS and pmLysRS, which are produced by
alternative splicing of exon 2 of the KARS gene [12], share the
same catalytic domain, and have the intrinsic capacity to bind
Pol [11], only the mLysRS species is recovered within the
virions [6,10]. This suggests that the LysRS species are strictly
targeted in cellulo, which prevents association of mLysRS
with p38 in the cytosolic multi-aminoacyl-tRNA synthetase
complex, and of cLysRS with GagPol in HIV-1 infected cells
[11]. In order to get a precise view of the composition of the
tRNA packaging complex, we explored the possibility that
another yet unidentified viral protein could be involved in the
assembly of this complex. We analyzed the capacity of the
Env polyprotein precursor, and of the auxiliary proteins Vif,
Vpr, Tat, Rev, Vpu and Nef of HIV-1 to interact with LysRS,
and to participate in the assembly of the GagPol:m-
LysRS:tRNA3
Lys packaging complex. Then, we showed thate of HIV-1 is shown. The polyproteins Gag, GagPol and Env, and proteins Vif,
me. The viral (pHIV-1) proteins were expressed fused to LexA in pEG202. (B)
ysRS, or pmLysRS, was conducted in EGY48 strain. The three LysRS species
ysRS) enzymes were expressed fused to the B42 transcription activator, under
grew on a galactose medium in the presence of leucine (YNBGal þ L). When
, a protein:protein interaction resulted in the expression of the LEU2 gene, as
Rev or Tat. If the expression of LEU2 requires interaction between LysRS and
m (YNB) where LysRS is not expressed. All the strains grew on YNB in the
produced in yeast. Left: Western blot analysis of the fusion proteins expressed
Da) were expressed fused to the HA11 hemagglutinin epitope. Right: Western
. The Vif (45.3 kDa), Vpu (31.8 kDa), Tat (32.5 kDa), Rev (35.7 kDa), Vpr
sed to the LexA DNA-binding domain.
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Lys can be readily accommodated in vitro into the
complex made of mLysRS and of the Pol domain of GagPol.
2. Materials and methods2.1. Yeast two-hybrid analysisThe yeast two-hybrid system developed by Brent et al. was
used [13]. The Vif, Tat, Rev, Vpu and Env coding regions from
pNL4-3 were introduced between the EcoRI and XhoI sites of
pEG202. The Vpr and Nef coding regions were introduced
between the BamHI and XhoI sites, or EcoRI and NcoI sites of
pEG202, respectively. The LexA DNA-binding domain-fused
proteins in pEG202 are expressed under the control of a
constitutive promoter. To test whether the LexA:pVIH-1
fusion proteins are able to enter the nucleus and bind LexA
operators, the repression assay with the pJK101 reporter was
used [13]. The cDNAs encoding the human cytoplasmic,
premitochondrial and mitochondrial forms of LysRS, the
catalytic (CAT, from Asp238 to Val597), anticodon-binding
(ABD, from Val71 to Asn237), or eukaryotic-specific
(cESD, mESD, pmESD, from their respective N-terminus to
Ser70) domains of LysRS introduced between the EcoRI and
XhoI sites of pJG4-5 have been described [11]. The B42
activation domain-fused proteins in pJG4-5 also carry
a hemagglutinin epitope tag, and are expressed under the
control of a galactose-inducible promoter.
The yeast strain EGY48 (Mata his3 leu2::3LexAop-LEU2
ura3 trp1) which contains a chromosomal LEU2 gene placed
under the control of LexA operators was transformed to hisþ
with pEG202-derivatives and to trpþ with pJG4-5 derivatives.
At least four independent colonies were analyzed for their
ability to grow in the absence of leucine (expression of Lexop-
LEU2). A pair of interactive proteins was scored as positive
when transformants did not grow on glucose medium lacking
leucine (no expression of B42-fusions) but grew on galactose
medium lacking leucine (expression of B42-fusions that
interacted with LexA-fusions).2.2. ImmunoprecipitationThe Rev, Vpr, Tat and Nef coding sequences from pNL4-3
were inserted into the BglII site of pRS315-PGK (CEN/ARS,
LEU2 [14]). FLAG-tagged proteins were expressed with an N-
terminal MGDYKDDDDKPW sequence corresponding to the
FLAG epitope (underlined). Plasmids pRS315-PGK-FLAG or
pRS315-PGK-FLAG-(Rev, Vpr, Tat, or Nef) were used to
transform yeast W303-1Ba strain (leu2, his3, trp1, ura3,
ade2). Cells were grown at 28 C in 1 l of minimal YNB
medium (0.7% yeast nitrogen base without amino acid, 2%
glucose) supplemented with uracil, adenine, histidine and
tryptophan, to an A600 of 1. Cells were washed, resuspended in
5 ml of ice-cold extraction buffer (100 mM TriseHCl pH 8.0,
100 mM NaCl, 10 mM MgCl2, 1 mM DTT) and lysed at
2100 bar in a “One Shot” cell disrupter (Constant Systems
Ltd) in the presence of 1 mM benzamidine and 1 mM PMSF.
Extracts were clarified by centrifugation at 12,000 g for15 min at 4 C, followed by a 40 min centrifugation step at
160,000 g, at 4 C. The supernatant was incubated 2 h, at 4 C,
after addition of 120 ml of a 1:1 slurry of ANTI-FLAG M2
affinity gel (Sigma). The matrix was extensively washed and
resuspended in NETN50 (20 mM TriseHCl pH 8.0, 50 mM
NaCl, 1 mM EDTA, 0.5% NP40). Anti-FLAG agarose incu-
bated with an extract of yeast transformed with pRS315-PGK-
FLAG-Pol is denoted FLAG-Pol matrix, or FLAG matrix
when incubated with the control extract of yeast transformed
with pRS315-PGK-FLAG. Before incubation with purified
proteins, a fraction of the matrix was treated with SDS and
analyzed by Western blotting with anti-FLAG antibodies to
assess that similar amounts of the different FLAG-proteins
were bound to the matrix.
Purified mLysRS expressed in insect cells and purified as
described [10] was incubated (0.1 ml at 2 mM) with 30 ml of
FLAG or FLAG-(Rev, Vpr, Tat, or Nef) matrix in NETN50
containing BSA at 10 mg/ml. The mixture was incubated 1 h at
4 C with constant shaking. After centrifugation 1 min at 4 C
(13,000  g), agarose beads were washed twice with 200 ml
NETN50, once with 200 ml NETN250 (NETN50 containing
250 mM NaCl), and twice with 200 ml NETN50. Beads were
resuspended in 36 ml NETN50 and specific elution from
ANTI-FLAG M2 affinity gel was performed after addition of
4 ml of FLAG peptide (Sigma) at 5 mg/ml. After incubation for
30 min at 4 C, the supernatant was recovered by centrifu-
gation. Fractions were analyzed by Western blotting.2.3. Reconstitution of protein complexesThe Pol, IN, Rev and Vpr coding regions from pNL4-3 and
mLysRS sequences were introduced between the EcoRI and
XhoI sites of pFastBac1 (Life Technologies). The Pol and IN
sequences contain a His6 tag at the C-terminus. Recombinant
plasmids were integrated at the Tn7 transposition site of
EMBacY (gift from Imre Berger, EMBL, Grenoble) to give
the recombinant bacmids [15]. Initial baculoviruses were ob-
tained after transfection of adhesive Sf21 cells grown in Grace
medium supplemented with 10% FCS. Baculovirus amplifi-
cation was performed by infection of Sf21 cells grown in
suspension in SF-900 II medium (Life Technologies). To ex-
press recombinant proteins, baculoviruses were used to infect
High Five cells grown in suspension in Express Five SFM
medium (Life Technologies). After 48e56 h of culture at
27 C, cells were harvested by centrifugation, washed with
ice-cold PBS, and the cell pellet was stored at 80 C. Cells
were lysed by addition of 1 vol. of ice-cold extraction buffer
(20 mM K-phosphate pH 7.5, 150 mM NaCl, 10 mM imid-
azole, 5% glycerol, 5 mM 2-mercaptoethanol, 1% Triton X-
100) in the presence of 1 mM Pefabloc, 10 mM benzamidine
and 10 mM PMSF. Extracts were clarified by centrifugation at
12,000 g for 15 min at 4 C. The cell extracts containing
different recombinant proteins were mixed as described,
incubated 1 h at 4 C. After addition of 1 vol. of buffer A-
NiNTA (20 mM K-phosphate pH 7.5, 500 mM NaCl, 50 mM
imidazole, 5% glycerol, 5 mM 2-mercaptoethanol), the
mixture was incubated with 20 ml of a 1:1 slurry of Ni-NTA
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with 4  1 ml of buffer A-NiNTA, and elution was performed
by adding 2  200 ml of buffer B-NiNTA (20 mM K-phos-
phate pH 7.5, 500 mM NaCl, 400 mM imidazole, 5% glycerol,
5 mM 2-mercaptoethanol). Eluted proteins were analyzed by
western blotting. Where indicated, tRNA3
Lys was added during
incubation of cell extracts. Human tRNA3
Lys was produced in
Escherichia coli JM101Tr transformed with plasmid pBSTK3
[16] and purified as described [17].2.4. Antibodies and western blot analysisMonoclonal antibodies directed to the hemagglutinin
epitope were from BAbCo. Polyclonal antibodies to LexA
were a gift of Patrice Moreau (Laboratoire de Chimie
Bacterienne, Marseille). Polyclonal anti-DNLysRS antibodies
have been described previously [18]. Monoclonal anti-IN and
anti-Rev antibodies were from Abcam. Polyclonal anti-Vpr
antibodies were a gift from Uwe Tessmer (Heinrich-Pette-
Institute, Hamburg, Germany). Western blot analyses were
conducted with goat anti-rabbit or goat anti-mouse secondary
antibodies conjugated with peroxidase (Chemicon) and the
SuperSignal West Pico chemiluminescent substrates (Pierce).2.5. Northern blot analysisAn oligonucleotide (K3) complementary to the region
ranging from nucleotide 27 to nucleotide 52 of tRNA3
Lys was
labeled with digoxigenin-ddUTP as described by the supplier
(Roche). After electrophoresis on a 15% polyacrylamide gels
containing 8 M urea, tRNA was electrotransfered to a nylon
membrane (Nytran 0.45 mm, Schleicher & Schuell), hybrid-
ized to the labeled probe, and revealed with the DIG lumi-
nescent detection kit (Roche), as recommended by the
supplier.
3. Results3.1. Search for viral proteins interacting with lysyl-tRNA
synthetaseTable 1
b-Galactosidase activity in the repression assay.a
Plasmid used %
pRS313b 100
pEG202c 17 ± 3
pEG202-Vif 79 ± 5
pEG202-Vpu 67 ± 4
pEG202-Tat 21 ± 2
pEG202-Rev 23 ± 2
pEG202-Vpr 21 ± 3
pEG202-Nef 121 ± 10
pEG202-Env 75 ± 6
a Activity is expressed as the percentage of
activity in the given strain as compared to the
activity determined in the control strain that does
not express LexA (pRS313).
b Control plasmid that does not express LexA.
c Control plasmid that expresses wild-type
LexA.We previously determined that the Pol domain of GagPol,
but not the Gag domain, interacts with the catalytic domain of
mLysRS. More specifically, mLysRS interacts with the N-
terminal (TF) and C-terminal (IN) domains of the Pol region
of GagPol (Fig. 1A) [11]. Despite the fact that only mLysRS is
recovered into viral particles [6], cLysRS which shares its
catalytic domain with mLysRS has also the intrinsic ability to
interact with Pol in vitro. Now, we performed an exhaustive
search to investigate the putative role of the other HIV-1 viral
proteins in establishing a specific tRNA packaging complex
with mLysRS. All the viral proteins, except Gag and GagPol
which were used in previous studies [11], were subjected to a
protein:protein interaction search with mLysRS. This included
the Env polyprotein precursor, gp160, specifying the surface
(SU, gp120) and transmembrane (TM, gp41) glycoproteins, as
well as the auxiliary proteins Vif, Vpr, Tat, Rev, Vpu and Nef(Fig. 1A). Association of LysRS with these viral proteins was
first screened by the yeast two-hybrid method. The viral se-
quences were expressed fused with the LexA DNA-binding
domain, and fusion proteins of the expected sizes were
detected by western blot (Fig. 1C). The fusion proteins have to
be present in the nucleus to activate transcription in the two-
hybrid assay. To ascertain that the encoded proteins were at
least in part translocated into the yeast nucleus, we used the
repression assay developed by Brent et al. [13]. Briefly, a lacZ
reporter gene is placed under the control of a GAL1 promoter
that also contains a LexA operator. When LexA or a LexA-
fusion protein binds LexA operator, expression of lacZ is
repressed, leading to a reduced synthesis of b-galactosidase
[13]. With the exception of LexA-Nef, all other fusion proteins
repressed lacZ expression to different extents, exemplifying
their presence in the nucleus (Table 1). The cytoplasmic,
mitochondrial and premitochondrial LysRS species, cLysRS,
mLysRS and pmLysRS, were expressed in yeast fused with the
B42 transcription activation domain. These constructs also
contain a nuclear localization signal that targets them to the
nucleus and an HA11 hemagglutinin epitope that allows
identification of the fusion proteins expressed in yeast
(Fig. 1C).
Expression on galactose medium (YNBG, Fig. 1B) of
LexA-Rev, LexA-Vpr or LexA-Tat with B42-cLysRS, B42-
mLysRS or B42-pmLysRS allowed yeast EGY48 to grow in
the absence of leucine, suggesting that all these protein pairs
are able to associate through protein:protein interactions. On a
glucose medium (YNB, Fig. 1B), where B42-fusion proteins
are not expressed, no growth was observed, also suggesting
that interaction between Rev, Vpr or Tat with LysRS is
necessary for growth. In the case of LexA-Nef, growth was
independent of the expression of LysRS (Fig. 1B, YNB and
YNBG), suggesting that LexA-Nef by itself activates tran-
scription, a false positive usually observed with proteins car-
rying acidic patches [13]. This observation is also consistent
with the results of the repression assay (Table 1), showing that
the level of b-galactosidase expressed in the presence of
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when no repression occurs. Expression of Vif, Vpu or Env
with any of the three forms of LysRS did not lead to expres-
sion of LEU2.3.2. Identification of the protein domain of LysRS
involved in its interaction with viral proteinsBecause Rev, Vpr and Tat were scored positive by the yeast
two-hybrid assay with the three forms of LysRS, this sug-
gested that a domain common to all LysRS species was
involved in their association.
The structural domains of LysRS (Fig. 2A) were indepen-
dently expressed fused to B42 (Fig. 2B). This includes the C-
terminal catalytic domain of LysRS (CAT), its tRNA
anticodon-binding domain (ABD), and its N-terminal
eukaryote-specific sequences (ESD) that promote the forma-
tion of a stable complex between tRNALys and LysRS in
humans [7]. The cESD, mESD and pmESD domains also
contain the cytoplasmic-, mitochondrial- and
premitochondrial-specific sequences, respectively. Expression
of CAT, but of none of the other cESD, mESD, pmESD, or
ABD domains, with Rev, Vpr or Tat, revealed a proteine-
protein interaction (Fig. 2A). No interaction was detected with
Vif, Vpu or Env. As observed above, expression of Nef leads
to expression of the LEU2 gene in the absence of LysRS
expression, consistent with its peculiar ability to activate
transcription in yeast.3.3. Control of protein:protein interactions by
immunoprecipitationTo evaluate the validity of the protein:protein interactions
detected between Rev, Vpr and Tat with LysRS by the two-
hybrid assay, association of mLysRS with these three pro-
teins was assessed by immunoprecipitation of LysRS with
FLAG-tagged viral proteins produced in yeast (Fig. 3). The
viral proteins were expressed in yeast with a FLAG-tag
appended to their N-terminus, and purified by adsorption on
anti-FLAG agarose. The resulting FLAG-proteins bound to
anti-FLAG agarose, or an aliquot of anti-FLAG agarose
saturated with FLAG peptide, were incubated in the presence
of purified mLysRS. After washing of agarose beads, specific
elution of interacting proteins was accomplished by adding an
excess of FLAG peptide that released FLAG-proteins from the
agarose matrix by competition. mLysRS was recovered with
FLAG-Rev and FLAG-Vpr, but mLysRS was not recovered
from FLAG-Tat or from FLAG alone (Fig. 3).
This immunoprecipitation assay was also conducted with
FLAG-Nef, because, as described above, the association be-
tween Nef and LysRS could not be appraised by the yeast two-
hybrid approach. mLysRS did not significantly interact with
Nef in this assay (Fig. 3).
Thus, only Rev and Vpr showed a robust association with
mLysRS by the two-hybrid and immunoprecipitation ap-
proaches and were considered for further experiments. The
putative association between Tat and LysRS was onlyobserved by the two-hybrid assay, and was not judged as
robust.3.4. Rev and Vpr do not associate to mLysRS within the
Pol:mLysRS complexTo assemble and isolate the tRNALys packaging complex,
containing GagPol, mLysRS and tRNALys, the GagPol protein
precursor, or the Pol polyprotein only, both expressing an
inactive protease domain, and mLysRS were expressed in in-
sect cells. The baculovirus expression system allows synthesis
of proteins in a eukaryotic expression system closely
mimicking the translation machinery of a human cell, where
HIV-1 proteins are naturally expressed. The level of expres-
sion of GagPol was low, and the polyprotein was rapidly
degraded by cellular proteases into individual components.
Thus, we chose to associate mLysRS with Pol, which contains
the two domains TF and IN required to establish a potent
interaction with mLysRS (Figs. 4 and 5).
Pol was expressed with a C-terminal His-tag allowing its
recovery on a NiNTA column. An extract of insect cells
expressing Pol was mixed with an extract of insect cells
expressing mLysRS in excess as compared to Pol, and
incubated for 1 h before recovery of Pol on a NiNTA matrix.
As observed Fig. 4C, mLysRS was recovered with Pol,
showing that the Pol:mLysRS complex easily forms between
the two proteins. It is noticeable that Pol-H6 appears as a
doublet in the input fraction (Fig. 4A), but as a single band in
the output fraction (Fig. 4B, but also Fig. 5 below). The
lower band of the doublet corresponds to a degradation
product of Pol, with a deletion of its N-terminal TF domain.
Therefore, because the IN:mLysRS interaction is the only
one that can form with this truncated derivative of Pol, its
affinity for mLysRS was much weaker and it was not
recovered in the pull-down fraction. When Pol and mLysRS
were coexpressed in insect cells after coinfection with the
two baculovirus species, the Pol:mLysRS complex could also
be recovered after incubation with NiNTA matrix directly
after cell lysis (not shown).
Because Rev and Vpr bind to the free form of mLysRS, we
analyzed their ability to bind mLysRS into the Pol:mLysRS
complex. Vpr and Rev were expressed in the baculovirus
expression system, and the effect of the addition of these two
proteins on the assembly of the Pol:mLysRS complex was
analyzed as described above (Fig. 4). As a control, the inte-
grase (IN) domain of Pol, corresponding to one of the two
domains of Pol interacting with mLysRS [11], expressed in
insect cells with a C-terminal His-tag, was also used.
Viral proteins IN, Vpr or Rev were incubated alone, with
Pol, with mLysRS, or with Pol and mLysRS (Fig. 4A). The
protein samples recovered on NiNTA matrix contained the
His-tagged proteins Pol and IN, where applicable, but did not
contain Vpr or Rev (Fig. 4B), showing that Vpr and Rev,
which associated with free mLysRS (Fig. 3), do not interact
with mLysRS into the Pol:mLysRS complex (Fig. 4B). In
addition, this experiment also shows that Vpr and Rev do not
interact with Pol. The amount of mLysRS recovered with Pol
Fig. 2. Two-hybrid analysis of the LysRS domains interacting with pHIV-1. (A) The cytoplasmic- (cESD), mitochondrial- (mESD), or premitochondrial- (pmESD)
eukaryote-specific domains, the anticodon-binding domain (ABD), and the catalytic domain (CAT) of LysRS were expressed fused to the B42 transcription
activator, under the control of a galactose-inducible promoter in pJG4-5. The two-hybrid protein:protein interaction assay between the LysRS constructs and the
pHIV-1 constructs expressed fused to LexA in pEG202, was conducted in EGY48 strain. Expression of the CAT domain alone was as efficient as the expression of
the three full-length LysRS species to restore growth in the presence of Vpr, Rev, or Tat. No growth was observed on YNB plates, except for the strain expressing
the Nef construct. These data also show that none of the HA-LysRS fusions activate transcription of the reporter gene in the absence of a suitable B42-fusion
protein. For clarity, only the YNBGal selection plate is shown. (B) Expression of the fusion proteins in yeast was analyzed by Western blot. The cESD
(19.3 kDa), mESD (21.1 kDa), pmESD (22.7 kDa), ABD (31.1 kDa) or CAT (53.1 kDa) domains of LysRS, were expressed fused to the HA11 hemagglutinin
epitope.
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presence of Vpr or Rev (Fig. 4C), showing that their presence
did not impair association of mLysRS with Pol. By contrast,
when IN was added in excess in the presence of Pol, more
mLysRS was recovered from the NiNTA matrix (Fig. 4C),
consistent with the observation that IN, carrying a His-tag, is
also able to associate with mLysRS, as observed when
mLysRS is incubated with IN alone (Fig. 4C). Thus theinteraction between mLysRS and Vpr or Rev observed Fig. 3,
is abolished in the presence of Pol, suggesting that the sites of
interactions of Vrp and Rev on mLysRS are overlapping with
the sites of interaction with Pol, and that the later are much
more robust. Altogether, these data show that the functional
significance of the interaction between mLysRS and Rev or
Vpr, if any, is likely not to be involved in the assembly of the
tRNALys packaging complex.
Fig. 3. Co-immunoprecipitation of mLysRS with HIV-1 proteins. Anti-FLAG
agarose beads carrying FLAG peptide (FLAG) or the FLAG-Rev, FLAG-Vpr,
FLAG-Tat or FLAG-Nef fusion proteins were incubated with the mitochon-
drial species of LysRS (Input). After removal of the unbound fraction, beads
were washed and then incubated with FLAG peptide in excess, and the eluted
fraction was recovered (FLAG elution). mLysRS present in these fractions was
analyzed by Western blotting with anti-DNLysRS antibodies. The ‘Input’ and
‘Unbound’ fractions were diluted 10.
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Pol:mLysRS:tRNA3
LysThe functional role of association of mLysRS to GagPol is
to carry tRNALys to viral particles during the packaging pro-
cess. To test whether the Pol:mLysRS complex observed in
Fig. 4 can accommodate tRNA3
Lys to build the Pol:m-
LysRS:tRNA3
Lys packaging complex, extracts of insect cells
containing Pol-H6 and mLysRS were also supplemented with
tRNA3
Lys in excess (1 mM in the incubation mixture) (Fig. 5).
The addition of tRNA3
Lys during incubation of Pol-H6 with
mLysRS did not impair the recovery of mLysRS with Pol in
the pull-down fraction (Fig. 5A). The amount of tRNA3
Lys
recovered in the pull-down fraction obtained in the presence of
the two proteins, Pol and mLysRS, was much above the
background level observed with Pol or mLysRS alone
(Fig. 5B). This experiment recapitulates the assembly of the
three components into the tRNA3
Lys packaging complex.
4. Discussion
We previously showed that association of HIV-1 GagPol
with the cellular protein mLysRS to form the GagPol:mLysRS
complex involves interaction of the TF and IN domains of the
Pol region of GagPol with the catalytic domain of mLysRS
[11]. Because a single gene encodes the cytoplasmic and
mitochondrial species of LysRS in human by means of alter-
native splicing [12], the three cellular species of LysRS,
cLysRS, pmLysRS, and mLysRS, share 576 amino acid resi-
dues, corresponding to the catalytic and anticodon-binding
domains. Accordingly, association of GagPol to the catalytic
domain of LysRS is not restricted, in vitro, to the mLysRSspecies [11]. However, cLysRS, a member of the cytosolic
multisynthetase complex MARS [19], is never recovered into
the virions [6], suggesting that its interaction with the p38
scaffold protein of MARS and its routing to this complex
prevents its interaction with GagPol in HIV-1 infected cells
[11].
In this study, we explored the possibility that another yet
unidentified viral protein could be a component of the
tRNA3
Lys packaging complex. We found that mLysRS is also
able to interact with the Rev and Vpr proteins, and determined
that this association mainly involves the catalytic domain of
mLysRS, common to the three LysRS species. Association of
cytoplasmic LysRS with Vpr was already described in another
study [20], but was suggested to be not highly specific [21]
since BSA added in excess could inhibit this interaction. In
the present study, interaction of Rev and Vpr with mLysRS is
displaced by Pol (Fig. 4), suggesting that these interactions are
not involved in the assembly of the GagPol:mLysRS:tRNA3
Lys
packaging complex. Indeed, we show that the Pol polyprotein,
mimicking GagPol, and mLysRS are sufficient to associate
tRNA3
Lys within the packaging complex. Since the complex
between Pol and mLysRS can form in the absence or in the
presence of tRNA3
Lys, this suggests that tRNA binding does not
induce large structural rearrangements on either Pol or
mLysRS. Structural changes induced on the synthetase
following tRNA binding could be tolerated by the flexibility of
the Pol polypeptide, as it may be expected for a polyprotein
containing flexible hinge peptides at the borders of its indi-
vidual domains.
The data presented in this paper suggest that cellular
compartmentalization is the key mechanism for selective tar-
geting of only mLysRS to HIV-1 virions. It also suggests that
mLysRS can fulfill other functions in the HIV-1 life cycle, via
its association to Vpr and Rev.
Viral protein R (Vpr), one of the regulatory/accessory
proteins encoded by HIV-1 genome, is involved in several
aspects of hostevirus interactions [22]. One of the main
cellular roles of Vpr seems to be induction of cell cycle arrest
in G2 following HIV-1 infection. Vpr causes hyper-
phosphorylation of Cdc2, a cyclin-dependent kinase that
regulates the cell cycle, through inhibition of the Cdc25
phosphatase and activation of the Wee1 kinase. A small
fraction of Vpr is also phosphorylated on Ser79 and is essential
for nuclear import of the HIV-1 genomic DNA preintegration
complex. An important role of Vpr in induction of apoptosis
through permeabilization of the mitochondrial membrane has
also been reported. Finally, association of Vpr with numerous
cellular proteins was observed. It is therefore conceivable that
association of Vpr with LysRS could regulate one or several
of these processes. For instance, association of Vpr with
mLysRS could be required to induce relocalization of
mLysRS in the cytoplasm of HIV-1 infected cells, as previ-
ously observed following exposure of HeLa cells to exoge-
nous Vpr [21]. The Vpr-assisted release of mLysRS from
mitochondria would be a prerequisite for its association with
tRNA3
Lys and GagPol to form the packaging complex. Alter-
natively, binding of cLysRS to Vpr could be a regulatory
Fig. 4. Rev and Vpr do not copurify with the mLysRS:Pol complex. The mLysRS species, Pol or IN with a C-terminal His-Tag (Pol, IN), Vpr and Rev were
expressed independently in insect cells. Extracts were mixed as indicated, and subjected to NiNTA-agarose pull-down. The fractions obtained before (A: Input) or
after (B: Output) NiNTA pull-down were analyzed by Western blotting with anti-IN (for Pol and IN), anti-Vpr, anti-Rev, or (C) with anti-LysRS antibodies.
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cycle arrest or nuclear import.
Rev, the Regulator of Expression of Virion proteins, is an
essential component of HIV involved in nuclear export of
intron-containing viral RNAs [23]. Rev is a nucleo-
cytoplasmic shuffling protein containing four functional do-
mains: a nuclear localization signal and a nuclear export signal
for efficient trafficking, an RNA binding domain and an
oligomerization domain involved in binding the Rev-
responsive elements located on unspliced or partiallyunspliced mRNAs. In the absence of Rev, unspliced RNAs are
not efficiently exported, and GagPol and Env are poorly
expressed. Rev functions as a molecular switch for the trans-
lation of viral proteins from unspliced transcripts, and several
cellular proteins were shown to regulate its activity. For
instance, a component of the translation machinery, the
eukaryotic initiation factor 5A (eIF-5A) has been shown to be
essential for Rev-mediated viral RNA export [24]. The finding
that LysRS, its cytosolic or mitochondrial counterpart could
also be involved in regulation of Rev functions opens new
Fig. 5. Association of mLysRS with Pol in the absence or in the presence of
tRNA3
Lys. Pol with a C-terminal His-Tag and mLysRS were expressed inde-
pendently in insect cells. Individual extracts or mixed extracts
(mLysRS þ Pol) were incubated in the absence (tRNA3Lys) or in the presence
(þtRNA3Lys) of tRNA3Lys and subjected to NiNTA-agarose pull-down. (A) The
initial fractions (Input) and the fractions obtained after NiNTA pull-down
(Output) were analyzed by Western blotting with anti-LysRS or anti-
integrase antibodies. (B) The presence of tRNA3
Lys in the corresponding
fractions was determined by Northern blotting with a digoxigenin-labeled
oligonucleotide complementary to tRNA3
Lys (K3). With Pol or mLysRS alone,
the background level of tRNA3
Lys recovered corresponds either to nonspecific
binding of tRNA on NiNTA beads, or to the binding of tRNA on proteins from
the total extracts that bind nonspecifically to the beads.
60 L. Kobbi et al. / Biochimie Open 2 (2016) 52e61perspectives on the role of this host protein on the biology of
HIV-1.
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